Cohen Klingenstein’s Pfizer PFE Stock Holding History

Cohen Klingenstein’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.07M	Hold	169,014	–	–	0.12%	85
2026 Q1	$4.75M	Hold	169,014	–	–	0.15%	70
2025 Q4	$4.21M	Hold	169,014	–	–	0.13%	74
2025 Q3	$4.31M	Hold	169,014	–	–	0.13%	74
2025 Q2	$4.1M	Sell	169,014 -165	-0.1%	-$3.85K	0.14%	77
2025 Q1	$4.29M	Buy	169,179 +2	+0%	+$52	0.16%	74
2024 Q4	$4.49M	Buy	169,177 +2	+0%	+$54	0.15%	70
2024 Q3	$4.9M	Buy	169,175 +2	+0%	+$58	0.17%	82
2024 Q2	$4.73M	Buy	169,173 +2	+0%	+$55	0.17%	79
2024 Q1	$4.69M	Sell	169,171 -52	-0%	-$1.44K	0.17%	81
2023 Q4	$4.87M	Buy	169,223 +2	+0%	+$60	0.2%	76
2023 Q3	$5.61M	Buy	169,221 +2	+0%	+$71	0.25%	65
2023 Q2	$6.21M	Buy	169,219 +2	+0%	+$78	0.27%	63
2023 Q1	$6.9M	Buy	169,217 +2	+0%	+$86	0.32%	56
2022 Q4	$8.67M	Buy	169,215 +201	+0.1%	+$9.64K	0.44%	47
2022 Q3	$7.4M	Hold	169,014	–	–	0.39%	49
2022 Q2	$8.86M	Hold	169,014	–	–	0.44%	42
2022 Q1	$8.75M	Hold	169,014	–	–	0.36%	50
2021 Q4	$9.98M	Sell	169,014 -17,180	-9%	-$851K	0.39%	45
2021 Q3	$8.01M	Buy	186,194 +195	+0.1%	+$8.64K	0.35%	58
2021 Q2	$7.28M	Hold	185,999	–	–	0.31%	61
2021 Q1	$6.74M	Hold	185,999	–	–	0.31%	64
2020 Q4	$6.85M	Sell	185,999 -10,044	-5%	-$368K	0.34%	61
2020 Q3	$6.83M	Hold	196,043	–	–	0.38%	57
2020 Q2	$6.08M	Hold	196,043	–	–	0.37%	60
2020 Q1	$6.07M	Hold	196,043	–	–	0.45%	52
2019 Q4	$7.29M	Buy	196,043 +14,440	+8%	+$514K	0.42%	55
2019 Q3	$6.19M	Hold	181,603	–	–	0.39%	59
2019 Q2	$7.46M	Buy	181,603 +75,218	+71%	+$2.99M	0.53%	47
2019 Q1	$4.29M	Buy	106,385 +15,717	+17%	+$629K	0.3%	66
2018 Q4	$3.75M	Hold	90,668	–	–	0.57%	28
2018 Q3	$3.79M	Hold	90,668	–	–	0.48%	31
2018 Q2	$3.12M	Hold	90,668	–	–	0.43%	36
2018 Q1	$3.05M	Hold	90,668	–	–	0.43%	42
2017 Q4	$3.12M	Hold	90,668	–	–	0.44%	40
2017 Q3	$3.07M	Hold	90,668	–	–	0.46%	34
2017 Q2	$2.89M	Hold	90,668	–	–	0.45%	37
2017 Q1	$2.94M	Sell	90,668 -1,298	-1%	-$40.9K	0.47%	35
2016 Q4	$2.83M	Hold	91,966	–	–	0.48%	34
2016 Q3	$2.96M	Buy	91,966 +46,271	+101%	+$1.55M	0.51%	31
2016 Q2	$1.53M	Hold	45,695	–	–	0.28%	65
2016 Q1	$1.28M	Sell	45,695 -914	-2%	-$26.1K	0.24%	70
2015 Q4	$1.43M	Hold	46,609	–	–	0.27%	67
2015 Q3	$1.39M	Hold	46,609	–	–	0.27%	67
2015 Q2	$1.48M	Hold	46,609	–	–	0.27%	62
2015 Q1	$1.54M	Sell	46,609 -44	-0.1%	-$1.4K	0.28%	57
2014 Q4	$1.38M	Hold	46,653	–	–	0.26%	68
2014 Q3	$1.31M	Hold	46,653	–	–	0.23%	69
2014 Q2	$1.31M	Hold	46,653	–	–	0.25%	63
2014 Q1	$1.42M	Hold	46,653	–	–	0.28%	59
2013 Q4	$1.36M	Hold	46,653	–	–	0.27%	59
2013 Q3	$1.27M	Hold	46,653	–	–	0.28%	58
2013 Q2	$1.24M	Buy	+46,653	New	+$1.29M	0.29%	56

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Cohen Klingenstein's PFE Position: Q2 2026 in Review

Cohen Klingenstein held its Pfizer (PFE) position steady in Q2 2026 at 169,014 shares worth $4.07M. The position accounts for 0.12% of the portfolio, ranked #85.

Cohen Klingenstein first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.98M in Q4 2021. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cohen Klingenstein held 169,014 shares of Pfizer worth $4.07M as of Q2 2026.
Cohen Klingenstein left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.12% of Cohen Klingenstein's portfolio in Q2 2026, its #85 holding.
Cohen Klingenstein first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Cohen Klingenstein's Pfizer position peaked at $9.98M in Q4 2021.
1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.